Search - tctmd.com

Displaying 861 - 878 of 878

Sort: Relevancy | Date

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

Nonaccess Site Bleeding After PCI Strongly Tied to Long-term Mortality

March 08, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Industry News

Miracor reports successful completion of the ‘Prepare PICSO’ clinical trial

March 03, 2011

News Daily News

Meta-analysis: Multivessel PCI Comparable to Culprit-Only Approach in STEMI

L.A. McKeown

March 03, 2011

News Daily News

Adjunctive Intracoronary Adenosine Lessens No-Reflow in AMI Patients

Jason Kahn

February 27, 2011

News Conference News

Adding FFR to Syntax Score Improves Predictive Ability

Caitlin E. Cox

February 17, 2011

News Daily News

Early GPI More Effective When Paired with Upstream Clopidogrel in NSTE ACS

Caitlin E. Cox

February 10, 2011

News Daily News

IVUS Study Investigates Mechanisms of DES Restenosis

Jason Kahn

February 06, 2011

News Daily News

IVUS Cannot Replace FFR But Can Help Rule Out Ischemia-Producing Stenoses

Caitlin E. Cox

February 01, 2011

News Daily News

Cell Therapy Trials Show Safety, Efficacy Signal in Critical Limb Ischemia

January 25, 2011

News Daily News

PROSPECT Published: Combined IVUS Identifies Risky Nonculprit ACS Lesions

Caitlin E. Cox

January 18, 2011

News Industry News

Merck Statement on Changes to Clinical Studies of Vorapaxar

January 12, 2011

News Daily News

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

January 11, 2011

News Daily News

Higher Long-term Mortality for Women Undergoing Primary PCI

Leah Lawrence

January 10, 2011

News Daily News

Cell Therapy Shows Promise for Limb Ischemia Due to PAD, Buerger’s Disease

Caitlin E. Cox

January 06, 2011

News Industry News

Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia

January 02, 2011

Advertisement

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

Studies Support DES Use in Diabetics, But Results Vary by Device

Nonaccess Site Bleeding After PCI Strongly Tied to Long-term Mortality

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Miracor reports successful completion of the ‘Prepare PICSO’ clinical trial

Meta-analysis: Multivessel PCI Comparable to Culprit-Only Approach in STEMI

Adjunctive Intracoronary Adenosine Lessens No-Reflow in AMI Patients

Adding FFR to Syntax Score Improves Predictive Ability

Early GPI More Effective When Paired with Upstream Clopidogrel in NSTE ACS

IVUS Study Investigates Mechanisms of DES Restenosis

IVUS Cannot Replace FFR But Can Help Rule Out Ischemia-Producing Stenoses

Cell Therapy Trials Show Safety, Efficacy Signal in Critical Limb Ischemia

PROSPECT Published: Combined IVUS Identifies Risky Nonculprit ACS Lesions

Merck Statement on Changes to Clinical Studies of Vorapaxar

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

Higher Long-term Mortality for Women Undergoing Primary PCI

Cell Therapy Shows Promise for Limb Ischemia Due to PAD, Buerger’s Disease

Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content